A poster presentation on LYR-210 will be featured at the ARS Annual Meeting and an oral presentation on LYR-220 will be featured at the AAO-HNS Annual Meeting.
In 2019, Mereo BioPharma completed the Phase 2b dose-finding study (ASTEROID) for setrusumab in 112 adults with OI. The ASTEROID study demonstrated treatment with setrusumab resulted in a clear, ...
The lunch event (catered by Ozark Catering) featured a 10-minute presentation by Thrasher on her work at Immerse, including research on the growth and continued projected growth of the use of VR in ...